• KSBB Journal
• /
• 제13권2호
• /
• pp.147-154
• /
• 1998

키토산 올리고당을 효율적으로 생산하기 위하여 고정화 효소 를 이용한 키토산의 효소적 가수분해를 시도하였다. Chitosanase는 Chitopearl계 고정화 담체에 대해서 높은 흡착율로 결합되었다. 키틴에 고정화된 효소는 비록 흡착율은 낮았지 만 그 활성은 가장 높게 나타났다. 키틴 고정화 효소는 유리 효소에 비해 약 90% 이상의 활성을 유지하였다. 고정화 효소의 최적 온도는 60°C로서 유리 효소보다 $15^{\circ}C$ 더 높았으며, 열에 대한 안정성도 유리 효소보다 넓은 온도범위에서 우수하였다 그러나 고정화 효소는 pH에 대해서는 어떠한 뚜렷한 효과도 보이지 않았다. 고정화 효소의 저장 안정성은 유리 효소보다 더 높은 저장온도인 60t에서도 더 안정한 것으로 나타났다. 키틴 고정화 효소에 의한 키토산의 가수분해반응은 반응 3시간까지 급격한 증가를 보이다 그 이후의 반응시간 경과에서도 더 이상 증가를 보이지 않았다. 고정화 효소에 의해 생성된 올리고당의 조성은 효소의 반응시간에 따라 크게 의존하였으며, 2시간의 반 응에서 비교적 고차 올라고당인 COS-4-6의 함량은 약 90% 이상이었다 두 효소에 대한 반용속도상수에서, 고정화 효소는 유리 효소에 비해 낮은 기질친화성과 낮은 반웅속도를 보였지 만, 높은 기질농도에서도 전혀 기질저해반응은 일어나지 않았다. 따라서 키틴 고정화 효소는 유리 효소에 비해 활성의 감소없이 효율적으로 키토산을 가수분해할 수 있었으며, 고차 올리고당의 생성 량도 매우 높았다.

• Journal of Nutrition and Health
• /
• 제36권9호
• /
• pp.908-917
• /
• 2003

It has been proposed that oxidative modification of LDL (oxLDL) plays a significant role in the pathogenicity of atherogenesis. We tested the hypothesis that chitin and chitosan may function as antioxidants with respect to 0.1 mg cholesterol/ml LDL incubated with 5 $\mu$ M Cu$^2$$^{+}$alone or in the P338Dl mouse macrophage system using L-ascorbic acid as a standard classical antioxidant. The degree of oxLDL formation was ascertained by the relative electrophoretic mobility (rEM) in the combination of thiobarbituric acid reactive substances (TBARS) levels, and the cytotoxicity of oxLDL was detected by macrophage viability. The oxLDL uptake and foam cell formation of macrophages were measured by Oil Red O staining. Incubation with Cu$^2$$^{+}$and macrophages increased rEM of LDL and stimulated TBARS formation. Culture of macrophages with LDL in the presence 5 $\mu$ M Cu$^2$$^{+}$induced macrophage death. In cell-free system 200 $\mu$g/ml water-soluble chitosan and chitosan-oligosaccharide blocked oxLDL formation. Water-soluble chitosan and chitosan-oligosaccharide blocked oxLDL formation near-completely relative to L-ascorbic acid, whereas water-soluble chitin and chitin-oligosaccharide had no measurable antioxidant effect. In macrophage system water-soluble chitosan and chitosan-oligosaccharide blocked oxidation of LDL with a significant increase in cell viability, and decreased TBARS in medium. As for the inhibitory effect on macrophage foam cell formation, chitosan and its oligosaccharide, but not watersoluble chitin, revealed the effectiveness. The endothelial expression of lectin-like oxLDL receptor-1 (LOX-1) was tested by Western blot analysis, and chitosan, chitosan-oligosaccharide and chitin-oligosaccharide blocked LOX-1 expression. These results indicate that water-soluble chitosan and its oligosaccharide showed the inhibitory effect on Cu$^2$$^{+}$-induced LDL oxidation of macrophages, and chitosan, chitosan-oligosaccharide and chitin-oligosaccharide had blocking effect on oxLDL receptor expression in the human umbilical vein endothelial system. Thus, water-soluble chitosan and its oligosaccharides possess anti-atherogenic potentials possibly through the inhibition of macrophage LDL oxidation or endothelial oxLDL receptor expression depending on chemical types.l types.

• Journal of Applied Biological Chemistry
• /
• 제52권2호
• /
• pp.84-87
• /
• 2009

• KSBB Journal
• /
• 제17권1호
• /
• pp.100-105
• /
• 2002

중합도 n$\leq$10을 갖는 N-아세틸-D-글루코사민(GlcNAc)을 미생물 Serratia marcesce-ns QM B14f6의 최소배지 회분식 발효를 이용하여 키틴 및 키토산을 분해하는 효소 키티나제(1.5 unit/mL) [키토바이아제(3.48 unit/mL)가 포함됨]를 생성시킨다. 효소 반응에 의한 키토올리고당의 생성 활성을 규명하기 위하여 부분적으로 탈아세틸화된 키토산을 효소적 가수분해 반응시킴으로써 생성된 N-아세틸-D-글루코사민과 D-글루코사민의 키토올리고당의 생성 패턴을 확인 조사한다. 이 혼합 올리고머로부터 CM-Sephadex의 컬럼 크로마토그래피에 의하여 당별로 분획시켜 추출한 헤테로 키토 올리고당들을 각각 N-아세틸화하고 이 최종 생성물을 전기투석 장치로서 정제하여 키토올리고 1-7당을 제조하였다. 부분적으로 탈아세틸화 키토산(환원당으로서 2697 mg/mL)을 효소반응에 의해 생성시킨 키토올리고당은 1당으로서 GlcNAc=4.25%, 2당 $(GlcNAc)_2$=4.49%, 3당 $(GlcNAc)_3$=11.1%, 4당 $(GlcNAc)_4$=2.5%, 5당 $(GlcNAc)_{5}$ =0.64%, 6당$(GlcNAc)_{6}$=2.12%, 7당 $(GlcNAc)_{7}$=1.21%가 각각 제조되었다.

• Macromolecular Research
• /
• 제12권6호
• /
• pp.573-580
• /
• 2004

To prepare chitosan-based polymeric amphiphiles that can form nanosized core-shell structures (nanopar­ticles) in aqueous milieu, chitosan oligosaccharides (COSs) were modified chemically with hydrophobic cholesterol groups. The physicochemical properties of the hydrophobized COSs (COSCs) were investigated by using dynamic light scattering and fluorescence spectroscopy. The feasibility of applying the COSCs to biomedical applications was investigated by introducing them into a gene delivery system. The COSCs formed nanosized self-aggregates in aqueous environments. Furthermore, the physicochemical properties of the COSC nanoparticles were closely related to the molecular weights of the COSs and the number of hydrophobic groups per COS chain. The critical aggregation concentration values decreased upon increasing the hydrophobicity of the COSCs. The COSCs effi­ciently condensed plasmid DNA into nanosized ion-complexes, in contrast to the effect of the unmodified COSs. An investigation of gene condensation, performed using a gel retardation assay, revealed that $COS6(M_n=6,040 Da)$ containing $5\%$ of cholesteryl chloroformate (COS6C5) formed a stable DNA complex at a COS6C5/DNA weight ratio of 2. In contrast, COS6, the unmodified COS, failed to form a stable COS/DNA complex even at an elevated weight ratio of 8. Furthermore, the COS6C5/DNA complex enhanced the in vitro transfection efficiency on Human embryonic kidney 293 cells by over 100 and 3 times those of COS6 and poly(L-lysine), respectively. Therefore, hydrophobized chitosan oligosaccharide can be considered as an efficient gene carrier for gene delivery systems.

• Asian-Australasian Journal of Animal Sciences
• /
• 제16권5호
• /
• pp.706-713
• /
• 2003

Two experiments were conducted to evaluate the efficacy of dietary FERMKIT, a commercial toxin binder consisting of probiotic-fermented natural product containing chitin, chitosan and chitosan oligosaccharides ($FERMKITO^{(R)}$, EASY-BIO SYSTEM, Inc., Korea), in binding aflatoxin (AF) and zearalenone (ZEN) and ameliorating their mycotoxicity in meat type ducks. FERMKIT was supplemented to AF contaminated diets (at 120 ppb) at either 0.3 or 0.6% in experiment 1 and to ZEN contaminated diets (at 150 ppb) at 0.6% in experiment 2. In experiment 1 body weight gains were reduced by 37% and mortality was increased by 18% in ducks fed diet contaminated with AF at 120 ppb compared to ducks fed control diet (<10 ppb AF) for the 4-wk experimental period. However, dietary FERMKIT supplementation effectively alleviated overall toxicity induced by AF. The significant treatment-related changes in feather growth, web-toe hemorrhage, leg deformity, liver paleness, organ weights, hematological values and serum biochemical values, as compared to the control, were observed. The FERMKIT supplementation significantly diminished the adverse effects of AF and restored all the parameters measured back (<0.05) toward the control values. These findings indicated that FERMKIT, when added at the levels of 0.3 or 0.6% in the 120 ppb AF diets, could modulate the toxicity of AF with percentage sorption capacity of 52.70% at the level 0.3% and 79.85% at the level 0.6% of the diets (experiment 1). In experiment 2, FERMKIT, when added at 0.6% to the 150 ppb ZEN diets for the 4-wk experimental period, diminished the toxicity as shown by body weight gain, weights of testicles, oviducts, Bursa of Fabricius and cloaca eversion score as compared with the controls (<10 ppb ZEN) and 150 ppb ZEN diet with no added FERMKIT. The findings indicated that FERMKIT could be protective against the effects of ZEN in young growing ducks with percentage sorption capacity of 67.11% as evaluated from toxicity index parameter measured when added at 0.6% of the diets containing 150 ppb ZEN.

• 한국해양바이오학회지
• /
• 제1권1호
• /
• pp.9-21
• /
• 2006

Foods and related substances from diverse sources known to have a potential for disease risk reduction are called functional foods, while nutraceuticals are bioactive compounds isolated from food and sold in dosage form. Nutraceutical and functional food industries are rapidly growing in recent years and most of the cases development of these functional materials involves certain biotransformation processes. A number of bioactive compounds has been identified up to date and isolated from seafood related products through enzyme-mediated hydrolysis. The enzymatic bioconversion process require suitable biocatalysts and appropriate bioreactor systems to incubate byproducts with digestive enzymes. Membrane bioreactor technology is recently emerging for the development of bioactive compounds from seafood processing byproducts.

• 한국어업기술학회:학술대회논문집
• /
• 한국어업기술학회 2001년도 추계 수산관련학회 공동학술대회발표요지집
• /
• pp.145-146
• /
• 2001

Despite a variety of development in fish farming during the last decades, fish diseases by bacteria, virus, and parasites are still major problems in aquaculture. Aquaculture of Hounder fish is widely performed around Korea as well as Jeju island, due to relatively stable seed production, short farming period, and a higher value in market. However, intensive feeding and environmental pollution in aquacutural farm act as a great limiting factor in economic aspect. (omitted)

• 한국어업기술학회:학술대회논문집
• /
• 한국어업기술학회 2001년도 추계 수산관련학회 공동학술대회발표요지집
• /
• pp.147-148
• /
• 2001

Many people living in Asia countries, particularly Korea, Japan and China, have consumed very widely fresh seafood products, such as shrimps, oysters, mussels and other marine invertebrates and fishes, without any heating or cooking. A variety of Vibrio spp., including V. parahaemolyticus, V. cholera. V. vulnificus, and V. fluvialis, lives in these seafoods and cause great problems associated with human disease. A strong antimicrobial agent to effectively inhibit the growth of these pathogenic bacteria in in vivo or in vitro is urgently need for preventing fish and human diseases. (omitted)

• Biotechnology and Bioprocess Engineering:BBE
• /
• 제5권5호
• /
• pp.345-349
• /
• 2000

To easily separate chitosanoligosaccharides by size exclusion, an coencapsulating technology of substrate and enzyme was developed. The membrane was composed of alginate and a divalent cation such as calcium. Chitosan and chitosanase were enveloped in this membrane and the product released to medium by size exclusion. The capsule was stabilized in a 2% acetic acid solution (pH 5.0) containing 0.145 M CaCO$_3$. The leakage of substrate caused by the agitation speed was controlled by increasing alginate and CaCO$_3$concentrations. The lower limit of the alginate concentration and the agitation speed were 0.5% and 49rpm, respectively. Membrane thickness and capsule diameter were 10$\mu\textrm{m}$ and 2.5mm, respectively. By TLC analysis, the composition of chitosanoligosaccharides were mainly 3-6 mers. The molecular weight distribution of the released oligosaccharides ranged from 262 to 3624 Da by GPC.